12.05
17-May-24 15:59:52
15 minutes delayed
Stocks
-0.20
-1.63%
Today's range
12.00 - 12.53
ISIN
N/A
Source
NASDAQ
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience to Present at Upcoming Investment Conferences
23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire